NBIX

152.9432.33%
EW

Eiry Wyn Roberts

Chief Medical Officer

Dr. Eiry Wyn Roberts, M.D. is Chief Medical Officer of Neurocrine Biosciences, Inc. from September 28, 2026 and Independent Director of Bausch Health Companies Inc. from May 19, 2026. Previously, Dr. Roberts served as Strategic Advisor at Neurocrine Biosciences, Inc. from June 02, 2025, until September 28, 2026 and as Chief Medical Officer from January 2018 until June 02, 2025. Dr. Roberts served as Independent Director at Amicus Therapeutics, Inc. from June 10, 2021, until April 27, 2026. At Eli Lilly and Company, Dr. Roberts served as Vice President of Research and Development, Clinical Pharmacology/Managing Director for Chorus from October 2014 until December 2017 and held positions including Vice President, Clinical Pharmacology and Vice President of R&D, BioMedicines Business Unit since May 1991. Dr. Roberts completed post-graduate clinical training in clinical pharmacology and cardiology at St. Bartholomew's Hospital and the Royal London Hospital. Dr. Roberts qualified from the University of London in 1987. Dr. Roberts earned a Bachelor of Science in Pharmacology from St Bartholomews Medical School in 1984 and a Doctor of Medicine from St Bartholomews Medical College in 1987.

Positions